{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:27Z","timestamp":1791357447296,"version":"4.3.1"},"reference-count":178,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.3109\/10673221003747955","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T10:09:35Z","timestamp":1272276575000},"page":"143-157","source":"Crossref","is-referenced-by-count":129,"title":["Bipolar Depression: Overview and Commentary"],"prefix":"10.1097","volume":"18","author":[{"given":"Ross J.","family":"Baldessarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.163.2.225","article-title":"Clinical features of bipolar depression vs. major depressive disorder in large multicenter trials.","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-5618.2007.00502.x","article-title":"Differences in outcome of DSM-IV bipolar I and II disorders.","volume":"10","author":"Mantere","year":"2008","journal-title":"Bipolar Disord"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4088\/JCP.08m04227","article-title":"McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.","volume":"70","author":"Salvatore","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/15622970009150569","article-title":"What is to be done: controversies in the diagnosis and treatment of manic-depressive illness.","volume":"1","author":"Ghaemi","year":"2000","journal-title":"World J Biol Psychiatry"},{"issue":"suppl 9","key":"R10-1-20210129","first-page":"271","article-title":"Misdiagnosis of bipolar disorder.","volume":"11","author":"Perlis","year":"2005","journal-title":"Am J Manag Care"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jad.2006.03.008","article-title":"Bipolar or unipolar: the question for clinicians and researchers.","volume":"93","author":"Kiejna","year":"2006","journal-title":"J Affect Disord"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2007.01.027","article-title":"History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder.","volume":"103","author":"Berk","year":"2007","journal-title":"J Affect Disord"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4088\/JCP.v69n0508","article-title":"Diagnosis of unipolar depression following initial identification of bipolar disorder: common and costly misdiagnosis.","volume":"69","author":"Stensland","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2008.10.007","article-title":"Classifying mood disorders by age-at-onset instead of polarity.","volume":"33","author":"Benazzi","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","article-title":"Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.","volume":"166","author":"Goldberg","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/15622970410029919","article-title":"Validating Kraepelins two types of depressive mixed states: depression with flight of ideas and excited depression.","volume":"5","author":"Akiskal","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(07)60453-X","article-title":"Bipolar disorder: focus on bipolar II disorder and mixed depression.","volume":"369","author":"Benazzi","year":"2007","journal-title":"Lancet"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2165\/00023210-200721080-00001","article-title":"Epidemiology, diagnosis and management of mixed mania.","volume":"21","author":"Gonzalez-Pinto","year":"2007","journal-title":"CNS Drugs"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-5618.2007.00561.x","article-title":"Bipolar II disorder: arguments for and against a distinct diagnostic entity.","volume":"10","author":"Vieta","year":"2008","journal-title":"Bipolar Disord"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2009.06.001","article-title":"The modified SCID Hypomania Module (SCID-Hba): detailed systematic phenomenologic probing.","volume":"117","author":"Benazzi","year":"2009","journal-title":"J Affect Disord"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/10673220500174833","article-title":"Manic-depressive illness: evolution in Kraepelins Textbook, 1883-1926.","volume":"13","author":"Trede","year":"2005","journal-title":"Harv Rev Psychiatry"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","article-title":"National trends in the outpatient diagnosis and treatment of bipolar disorder in youth.","volume":"64","author":"Maoreno","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MOP.0b013e32830fe3d2","article-title":"Pediatric bipolar disorder: recognition in primary care.","volume":"20","author":"Cummings","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.65.10.1125","article-title":"Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome.","volume":"65","author":"Geller","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1399-5618.2008.00659.x","article-title":"Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders.","volume":"11","author":"Birmaher","year":"2009","journal-title":"Bipolar Disord"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000406240","article-title":"Role of lithium as an antidepressant.","volume":"18","author":"Mendels","year":"1982","journal-title":"Mod Probl Pharmacopsychiatry"},{"issue":"suppl 8","key":"R28-1-20210129","first-page":"11","article-title":"Recognition and diagnosis of atypical depression.","volume":"68","author":"Thase","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpsyc.1993.01820130019004","article-title":"Seasonal mood disorders: patterns of seasonal recurrence in major affective disorders.","volume":"50","author":"Faedda","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1176\/ajp.155.10.1434","article-title":"Rapid cycling in women and men with bipolar manic-depressive disorders.","volume":"155","author":"Tondo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0327(99)00196-2","article-title":"Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.","volume":"61","author":"Baldessarini","year":"2000","journal-title":"J Affect Disord"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2006.12.005","article-title":"Bipolar and nonbipolar obsessive-compulsive disorder: clinical exploration.","volume":"48","author":"Zutshi","year":"2007","journal-title":"Compr Psychiatry"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.comppsych.2008.06.001","article-title":"Clinical significance of lifetime panic disorder in the course of bipolar disorder type I.","volume":"50","author":"Toniolo","year":"2009","journal-title":"Compr Psychiatry"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.64.1.57","article-title":"Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.","volume":"64","author":"Strakowski","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1399-5618.2007.00575.x","article-title":"Sequencing of substance use and mood changes in 166 first-episode bipolar I disorder patients.","volume":"10","author":"Baethge","year":"2008","journal-title":"Bipolar Disord"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jad.2009.06.016","article-title":"Fear of harm, a possible phenotype of pediatric bipolar disorder: dimensional approach to diagnosis for genotyping psychiatric syndromes.","volume":"118","author":"Papolos","year":"2009","journal-title":"J Affect Disord"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2009.05.022","article-title":"Early stages in the development of bipolar disorder.","volume":"121","author":"Duffy","year":"2010","journal-title":"J Affect Disord"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/070674370304800704","article-title":"Prophylaxis-latency and outcome in bipolar disorders.","volume":"48","author":"Baethge","year":"2003","journal-title":"Can J Psychiatry"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1399-5618.2007.00385.x","article-title":"Effects of treatment latency on response to maintenance treatment in manic-depressive disorders.","volume":"9","author":"Baldessarini","year":"2007","journal-title":"Bipolar Disord"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"Long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4088\/JCP.v64n0610","article-title":"Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.","volume":"64","author":"Post","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1399-5618.2003.00091.x","article-title":"Prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders.","volume":"6","author":"Joffe","year":"2004","journal-title":"Bipolar Disord"},{"key":"R44-1-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.105.013870","article-title":"Subsyndromal and syndromal symptoms in the longitudinal course of bipolar disorder.","volume":"189","author":"Paykel","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R45-1-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1399-5618.2008.00654.x","article-title":"Polarity at illness onset in bipolar I disorder and clinical course of illness.","volume":"11","author":"Forty","year":"2009","journal-title":"Bipolar Disord"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4088\/JCP.v63n0910","article-title":"Subsyndromal depression is associated with functional impairment in patients with bipolar disorder.","volume":"63","author":"Altshuler","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archpsyc.62.12.1322","article-title":"Psychosocial disability in the course of bipolar I and II disorders: prospective, comparative, longitudinal study.","volume":"62","author":"Judd","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.4088\/JCP.v67n1009","article-title":"Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study.","volume":"67","author":"Altshuler","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1399-5618.2008.00581.x","article-title":"Severity of mood symptoms and work productivity in people treated for bipolar disorder.","volume":"10","author":"Simon","year":"2008","journal-title":"Bipolar Disord"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2008.05.013","article-title":"Functional outcomes in first-episode patients with bipolar disorder: prospective study from the Systematic Treatment Optimization Program for Early Mania project.","volume":"50","author":"Kauer-SantAnna","year":"2009","journal-title":"Compr Psychiatry"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000207456","article-title":"Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients.","volume":"42","author":"Mur","year":"2009","journal-title":"Psychopathology"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-5618.2009.00698.x","article-title":"Clinical predictors of functional outcome of bipolar patients in remission.","volume":"11","author":"Rosa","year":"2009","journal-title":"Bipolar Disord"},{"key":"R55-1-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-5618.2009.00665.x","article-title":"Neurocognitive impairment in bipolar disorder patients: functional implications.","volume":"11","author":"Wingo","year":"2009","journal-title":"Bipolar Disord"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-0327(91)90016-L","article-title":"Five-year mortality in lithium-treated manic-depressive patients.","volume":"21","author":"Vestergaard","year":"1991","journal-title":"J Affect Disord"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","article-title":"Excess mortality in bipolar and unipolar disorder in Sweden.","volume":"58","author":"Osby","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","article-title":"Suicide in bipolar disorder: risk and prevention.","volume":"17","author":"Tondo","year":"2003","journal-title":"CNS Drugs"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2007.05.027","article-title":"Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.","volume":"106","author":"Khalsa","year":"2008","journal-title":"J Affect Disord"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0447.2007.01066.x","article-title":"Risks of suicidal ideation, attempts and suicides among 2826 men and women with types I and II bipolar, and recurrent major depressive disorders.","volume":"116","author":"Tondo","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R62-1-20210129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archpsyc.1978.01770350059005","article-title":"Secondary mania: manic syndromes associated with antecedent physical illness or drugs.","volume":"35","author":"Krauthammer","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"R63-1-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/070674370204700503","article-title":"Managing bipolar disorder during pregnancy: weighing the risks and benefits.","volume":"47","author":"Viguera","year":"2002","journal-title":"Can J Psychiatry"},{"key":"R64-1-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10673220902891802","article-title":"Treatise on insanity in pregnant, postpartum, and lactating women by Louis-Victor Marce (1858): a commentary.","volume":"17","author":"Trede","year":"2009","journal-title":"Harv Rev Psychiatry"},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ps.2007.58.1.85","article-title":"Prescribing patterns of psychotropic medicines in the United States for patients diagnosed with bipolar disorders.","volume":"58","author":"Baldessarini","year":"2007","journal-title":"Psychiatr Serv"},{"key":"R66-1-20210129","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Use of psychotropic medicines in bipolar disorder patients in the United States.","volume":"59","author":"Baldessarini","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R67-1-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1176\/appi.ajp.163.2.313","article-title":"Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.","volume":"163","author":"Altshuler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/YIC.0b013e3280c28410","article-title":"Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.","volume":"22","author":"Agosti","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4088\/JCP.v69n1009","article-title":"Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: systematic review and meta-analysis.","volume":"69","author":"Bond","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R70-1-20210129","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4088\/JCP.v69n1014","article-title":"International Consensus Group on the evidence-based pharmacological treatment of bipolar I and II depression.","volume":"69","author":"Kasper","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R71-1-20210129","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","article-title":"Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R72-1-20210129","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","article-title":"Randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.","volume":"63","author":"Vieta","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/appi.ajp.161.1.163","article-title":"Antidepressant treatment in bipolar vs. unipolar depression.","volume":"161","author":"Ghaemi","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R74-1-20210129","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertaline.","volume":"189","author":"Post","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R76-1-20210129","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression.","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"R77-1-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10673220802160381","article-title":"Antidepressants in the treatment of bipolar disorder: decoding contradictory evidence and opinion.","volume":"16","author":"Eppel","year":"2008","journal-title":"Harv Rev Psychiatry"},{"key":"R78-1-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0447.2008.01257.x","article-title":"Effectiveness of long-term antidepressant treatment in bipolar disorder: meta-analysis.","volume":"118","author":"Ghaemi","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R79-1-20210129","first-page":"121","article-title":"Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review.","volume":"45","author":"Harel","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"R80-1-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression: critical evaluation of their potential risk to induce switch into mania or cycle acceleration.","volume":"118","author":"Licht","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R81-1-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0447.2008.01233.x","article-title":"Antidepressants in bipolar depression.","volume":"118","author":"Vieta","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"R83-1-20210129","first-page":"64","article-title":"Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior Psychopharmacol B","volume":"42","author":"Mallinger","year":"2009","journal-title":"ull"},{"key":"R84-1-20210129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapinefluoxetine in combination in the treatment of bipolar I depression.","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R85-1-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"Seven-week, randomized, double-blind trial of olanzapinefluoxetine combination versus lamotrigine in treatment of bipolar I depression.","volume":"67","author":"Brown","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R86-1-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00023210-200822090-00006","article-title":"Spotlight on olanzapinefluoxetine in acute bipolar depression.","volume":"22","author":"Deeks","year":"2008","journal-title":"CNS Drugs"},{"key":"R88-1-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/JCP.0b013e3181ad223f","article-title":"Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: open-label, randomized, flexible-dose study in Puerto Rico.","volume":"29","author":"Tamayo","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R90-1-20210129","first-page":"114","article-title":"Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006;8:625-39;","volume":"10","author":"Baldessarini","year":"2008","journal-title":"comment"},{"key":"R91-1-20210129","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4088\/JCP.v63n0907","article-title":"Association between substance abuse and antidepressant-induced mania in bipolar disorder: preliminary study.","volume":"63","author":"Goldberg","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R92-1-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpedi.158.8.773","article-title":"Age effects on antidepressant-induced manic conversion.","volume":"158","author":"Martin","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R93-1-20210129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpedi.159.3.298-a","article-title":"Risk of mania with serotonin reuptake inhibitors vs. tricyclic antidepressants in children, adolescents and young adults.","volume":"159","author":"Baldessarini","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R94-1-20210129","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.4088\/JCP.v68n1002","article-title":"Self-reported history of manichypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).","volume":"68","author":"Truman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R95-1-20210129","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4088\/JCP.v69n1009","article-title":"Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: systematic review and meta-analysis.","volume":"69","author":"Bond","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R96-1-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.08m04191","article-title":"Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: blinded, randomized study.","volume":"70","author":"Altshuler","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R97-1-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.","volume":"166","author":"Frye","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R99-1-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.106.031088","article-title":"Efficacy of antidepressants in depressed children and adolescents: meta-analysis.","volume":"193","author":"Tsapakis","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R101-1-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/cmaj.081514","article-title":"Selective serotonin reuptake inhibitors and risk of suicide: systematic review of observational studies.","volume":"180","author":"Barbui","year":"2009","journal-title":"CMAJ"},{"key":"R102-1-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1399-5618.2003.00086.x","article-title":"Pharmacotherapy of bipolar II disorder: a critical review of current evidence.","volume":"6","author":"Hadjipavlou","year":"2004","journal-title":"Bipolar Disord"},{"key":"R103-1-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.eurpsy.2005.06.001","article-title":"Effective maintenance treatment breaking the cycle of bipolar disorder.","volume":"20","author":"Goodwin","year":"2005","journal-title":"Eur Psychiatry"},{"issue":"suppl 5","key":"R104-1-20210129","first-page":"17","article-title":"Reevaluating therapies for bipolar depression.","volume":"66","author":"Grunze","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R105-1-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11920-006-0055-6","article-title":"Pharmacotherapy of bipolar depression: an update.","volume":"8","author":"Thase","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"R106-1-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/14656566.8.1.13","article-title":"Bipolar depression: review of randomized clinical trials.","volume":"8","author":"Goodnick","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"R107-1-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15622970601083280","article-title":"Evolving trends in the long-term treatment of bipolar disorder.","volume":"8","author":"Vieta","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"R108-1-20210129","first-page":"1234","article-title":"Bipolar drug development: are we getting closer to the real world Am J P","volume":"165","author":"Calabrese","year":"2008","journal-title":"sychiatry"},{"key":"R109-1-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jad.2007.10.016","article-title":"Treatment of bipolar depression: an update.","volume":"109","author":"Fountoulakis","year":"2008","journal-title":"J Affect Disord"},{"key":"R110-1-20210129","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R111-1-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2008.10.2\/dekemp","article-title":"Bipolar depression: trial-based insights to guide patient care.","volume":"10","author":"Kemp","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"R112-1-20210129","first-page":"606","article-title":"Clinical inquiries: what drugs are best for bipolar depression J Fam P","volume":"57","author":"Ukaegbu","year":"2008","journal-title":"ract"},{"key":"R113-1-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14656560802653172","article-title":"Update on the treatment of bipolar depression.","volume":"10","author":"Azorin","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 2","key":"R114-1-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-5618.2009.00711.x","article-title":"Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.","volume":"11","author":"Malhi","year":"2009","journal-title":"Bipolar Disord"},{"key":"R115-1-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of guidelines for the management of patients with bipolar disorder: update 2009.","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"R116-1-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1461145709990344","article-title":"Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.","volume":"13","author":"Cruz","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R117-1-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/archpsyc.1973.04200030104017","article-title":"Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.","volume":"29","author":"Prien","year":"1973","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 41","key":"R118-1-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/bjp.178.41.s184","article-title":"Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.","volume":"178","author":"Tondo","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R119-1-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10673220216208","article-title":"Is lithium still worth using An update of selected recent research.","volume":"10","author":"Baldessarini","year":"2002","journal-title":"Harv Rev Psychiatry"},{"key":"R120-1-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R121-1-20210129","first-page":"474","article-title":"Lithium in mood disorders: increasing evidence base, declining use Br J P","volume":"191","author":"Young","year":"2007","journal-title":"sychiatry"},{"key":"R122-1-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0028-1103291","article-title":"Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants.","volume":"42","author":"Baldessarini","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"R123-1-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0447.2008.01343.x","article-title":"Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.","volume":"120","author":"Frye","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"R124-1-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00023210-200923030-00004","article-title":"Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"R125-1-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","article-title":"Meta-analysis of treatment responses of rapid-cycling and non-rapid-cycling bipolar disorder patients.","volume":"104","author":"Tondo","year":"2003","journal-title":"Acta Psychiatr Scand"},{"issue":"suppl 1","key":"R126-1-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.pra.0000333583.75741.8b","article-title":"Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review.","volume":"14","author":"Melvin","year":"2008","journal-title":"J Psychiatr Pract"},{"issue":"suppl 2","key":"R127-1-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-5618.2009.00708.x","article-title":"Anticonvulsants in bipolar disorders: current research and practice and future directions.","volume":"11","author":"Bowden","year":"2009","journal-title":"Bipolar Disord"},{"key":"R129-1-20210129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-199812000-00007","article-title":"Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.","volume":"18","author":"Greil","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R130-1-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4088\/JCP.v66n0204","article-title":"Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.","volume":"66","author":"Baethge","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R131-1-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hup.990","article-title":"Comparison of carbamazepine and lithium in treatment of bipolar disorder: systematic review of randomized controlled trials.","volume":"24","author":"Ceron-Litvoc","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"R132-1-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1034\/j.1399-5618.2003.00047.x","article-title":"Oxcarbazepine: clinical experience with hospitalized psychiatric patients.","volume":"5","author":"Centorrino","year":"2003","journal-title":"Bipolar Disord"},{"key":"R133-1-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"Double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.","volume":"11","author":"Vieta","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R134-1-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder.","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R135-1-20210129","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/sj.npp.1300190","article-title":"Maintenance efficacy of divalproex in the prevention of bipolar depression.","volume":"28","author":"Gyulai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R136-1-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.2005.00522.x","article-title":"Valproate in bipolar disorder: 2000 onwards.","volume":"426","author":"Bowden","year":"2005","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R137-1-20210129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1517\/17425250902911455","article-title":"Review of valproate in psychiatric practice.","volume":"5","author":"Haddad","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R139-1-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"Double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R140-1-20210129","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R141-1-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord"},{"key":"R142-1-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.","volume":"194","author":"Geddes","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R143-1-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: multi-center, double-blind, placebo-controlled trial.","volume":"70","author":"Van Der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R144-1-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4088\/JCP.v66n1106","article-title":"Typical and atypical antipsychotics in bipolar depression.","volume":"66","author":"Gao","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R145-1-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","article-title":"Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.","volume":"19","author":"Goodwin","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"R146-1-20210129","first-page":"19","article-title":"Update of evidence-based treatment of bipolar depression: where do we stand Curr Opin P","volume":"23","author":"Fountoulakis","year":"2010","journal-title":"sychiatry"},{"key":"R147-1-20210129","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R148-1-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"Randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R149-1-20210129","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: double-blind, placebo-controlled BOLDER II study.","volume":"26","author":"Thase","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"RU150-1-20210129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2008.06.019","article-title":"Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder.","volume":"111","author":"Endicott","year":"2008","journal-title":"J Affect Disord"},{"key":"RU151-1-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/15622970701317265","article-title":"Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.","volume":"9","author":"Suppes","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"RU152-1-20210129","first-page":"11","article-title":"Quetiapine monotherapy for bipolar depression.","volume":"4","author":"Thase","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R153-1-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4088\/JCP.v69n0510","article-title":"Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: post-hoc analysis of combined results from two double-blind, randomized, placebo-controlled studies.","volume":"69","author":"Weisler","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R154-1-20210129","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2009.00728.x","article-title":"Double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.","volume":"11","author":"DelBello","year":"2009","journal-title":"Bipolar Disord"},{"key":"R156-1-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127).","volume":"166","author":"Suppes","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R159-1-20210129","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: 12-month, randomized, double-blind, controlled clinical trial.","volume":"162","author":"Tohen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R160-1-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R162-1-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jad.2008.11.003","article-title":"Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.","volume":"116","author":"Tohen","year":"2009","journal-title":"J Affect Disord"},{"key":"R163-1-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of two randomized, placebo-controlled studies.","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R164-1-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.","volume":"14","author":"Berman","year":"2009","journal-title":"CNS Spectr"},{"key":"R165-1-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-859X-8-16","article-title":"Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"R166-1-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/NDT.S3763","article-title":"Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.","volume":"5","author":"Muzina","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R167-1-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740330902835493","article-title":"Review of the safety and tolerability of aripiprazole.","volume":"8","author":"Pae","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R168-1-20210129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12325-009-0039-0","article-title":"Long-acting risperidone: review of its role in the treatment of bipolar disorder.","volume":"26","author":"Kemp","year":"2009","journal-title":"Adv Ther"},{"key":"R169-1-20210129","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1755-5949.2008.00056.x","article-title":"Ziprasidone in the treatment of affective disorders: a review.","volume":"14","author":"Rosa","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"R170-1-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2009.01.022","article-title":"Ziprasidone monotherapy in bipolar II depression: open trial.","volume":"118","author":"Liebowitz","year":"2009","journal-title":"J Affect Disord"},{"key":"R172-1-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"Increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study.","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R173-1-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1399-5618.2003.00034.x","article-title":"Combination treatment in bipolar disorder: a review of controlled trials.","volume":"5","author":"Zarate","year":"2003","journal-title":"Bipolar Disord"},{"key":"R174-1-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00023210-200620010-00003","article-title":"Polytherapy in bipolar disorder.","volume":"20","author":"Lin","year":"2006","journal-title":"CNS Drugs"},{"key":"R175-1-20210129","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1517\/14656560903064170","article-title":"Treatment-refractory bipolar disorder: classification to aid in clinical management.","volume":"10","author":"Gajwani","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R176-1-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4088\/JCP.07m04022","article-title":"Six-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence.","volume":"70","author":"Kemp","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R177-1-20210129","first-page":"520","article-title":"Adjunctive use of modafinil in bipolar patients: just another stimulant or not Curr Psychiatry R","volume":"10","author":"Shelton","year":"2008","journal-title":"ep"},{"key":"R178-1-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega-3 fatty acids in bipolar disorder: preliminary double-blind, placebo-controlled trial.","volume":"56","author":"Stoll","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R179-1-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.apnu.2008.02.011","article-title":"Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review.","volume":"22","author":"Turnbull","year":"2008","journal-title":"Arch Psychiatr Nurs"},{"key":"R180-1-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1755-5949.2008.00061.x","article-title":"Omega-3 fatty acids in depression: a review of three studies.","volume":"15","author":"Osher","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"R181-1-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/15622970510029948","article-title":"Lithium and ECT: concurrent use still demands attention: three case reports.","volume":"6","author":"Sartorius","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"RU182-1-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jad.2008.03.024","article-title":"Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression.","volume":"112","author":"Hallam","year":"2009","journal-title":"J Affect Disord"},{"key":"RU183-1-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2009.01.014","article-title":"Response to ECT in bipolar I, bipolar II and unipolar depression.","volume":"118","author":"Medda","year":"2009","journal-title":"J Affect Disord"},{"key":"R184-1-20210129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biopsych.2009.02.018","article-title":"Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder.","volume":"66","author":"Wu","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R185-1-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-5618.2007.00430.x","article-title":"Disability and its treatment in bipolar disorder patients.","volume":"9","author":"Huxley","year":"2007","journal-title":"Bipolar Disord"},{"key":"R186-1-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archpsyc.64.4.419","article-title":"Psychosocial treatments for bipolar depression: one-year randomized trial from the Systematic Treatment Enhancement Program (STEP-BP).","volume":"64","author":"Miklowitz","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R187-1-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archpsyc.1993.01820180046005","article-title":"Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar mood disorders.","volume":"50","author":"Faedda","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"R188-1-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00045391-199607000-00004","article-title":"Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research.","volume":"3","author":"Baldessarini","year":"1996","journal-title":"Am J Ther"},{"key":"R189-1-20210129","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Recurrences of bipolar disorder in pregnancy: prospective study of mood-stabilizer discontinuation.","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R190-1-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2008.03.003","article-title":"ECNP consensus meeting. Bipolar depression. Nice, March 2007.","volume":"18","author":"Goodwin","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"R191-1-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpsyc.1997.01830130055011","article-title":"Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.","volume":"54","author":"Viguera","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R193-1-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/070674370304800410","article-title":"Switch to mania upon discontinuation of antidepressants in patients with mood disorders: review of the literature.","volume":"48","author":"Ali","year":"2003","journal-title":"Can J Psychiatry"},{"key":"R194-1-20210129","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4088\/JCP.08m04381","article-title":"Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.","volume":"70","author":"Goldberg","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"suppl 2","key":"R195-1-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-5618.2009.00711.x","article-title":"Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.","volume":"11","author":"Malhi","year":"2009","journal-title":"Bipolar Disord"},{"key":"R196-1-20210129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-5618.2009.00737.x","article-title":"International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.","volume":"11","author":"Ng","year":"2009","journal-title":"Bipolar Disord"},{"key":"R197-1-20210129","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.4088\/JCP.08r04972","article-title":"Effects of lithium on cognitive performance: a meta-analysis.","volume":"70","author":"Wingo","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R198-1-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society of Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome of bipolar disorders.","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord"},{"key":"R199-1-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0447.2006.00955.x","article-title":"Development of the bipolar inventory of symptoms scale.","volume":"116","author":"Bowden","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"R200-1-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/JCP.0b013e3181c9fdd3","article-title":"Empirical test of a basic assumption underlying survival analysis as applied to experimental therapeutics in psychopharmacology.","volume":"30","author":"Baldessarini","year":"2010","journal-title":"J Clin Psychopharmacol"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00023727-201004000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:19:54Z","timestamp":1618276794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201004000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":178,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.3109\/10673221003747955","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}